We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Biosensor Technology Will Offer Immunoassay at POC

By LabMedica International staff writers
Posted on 29 Dec 2008
A unique biosensor technology has the potential to offer lab-quality immunoassay results at point of care (POC).

The new technology, Magnotech, offers the possibility of taking certain complex in vitro diagnostic tests out of the laboratory and into a decentralized setting--including critical care treatment centers, ambulances, general practitioner clinics, and the home. More...
Its biggest impact is likely to be on improved patient outcomes and reduced healthcare costs.

Integrated into a disposable biosensor cartridge that inserts into a hand-held analyzer, Magnotech uses magnetic nanoparticles to measure target molecules in very low, picomolar concentrations in blood or saliva--in a few minutes. The main features of the Magnotech technology are: small sample volumes, ease of use, multianalyte systems, sensitive lab results, and speed.

Philips has demonstrated proof-of-concept for its new biosensor technology in a variety of biologic assays, including sandwich assays for the detection of cardiac Troponin I (cTnI), parathyroid hormone (PTH), and inhibition assays to detect several drugs-of-abuse molecules.

Currently, measuring very low concentrations of biomarkers for the diagnosis of, for example, cardiovascular disease, requires laboratory analysis, large sample volumes, and a time-to-result delay of between 30-60 min.

Royal Philips Electronics (Eindhoven, the Netherlands) unveiled the unique biosensor technology, Magnotech, on November 19-22 at Medica 2008, in Dusseldorf, Germany. Marcel van Kasteel, vice president and CEO of Philips Handheld Immunoassays, explained, "Longterm, we envisage that different testing stations--both conventional, automated labs, and these new, mobile handheld systems--will be part of a diagnostic network, using wired or wireless connectivity and sophisticated healthcare informatics solutions to store and assist in interpreting the data. Clinical decision support systems and data mining would be used to enable fast and accurate decision making."

Magnotech is the brainchild of Prof. Dr. Menno Prins, a research fellow at Philips Research, and professor at the Eindhoven University of Technology (TUE; Eindhoven, the Netherlands) where he is head of the "Molecular Biosensors for Medical Diagnostics” group.

Please see related links below for a video demonstrating the Magnotech technology.

Royal Philips Electronics is a leader in healthcare, lifestyle, and lighting. The company integrates technologies and design into people-centric solutions, based on fundamental customer needs and insights.

Related Links:
Royal Philips Electronics
Eindhoven University of Technology
Video: Magnotech technology


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Quality Control Material
Multichem ID-B
New
Celiac Disease Test
Anti-Gliadin IgG ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.